Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 71335-0392 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
The text describes a graph showing the proportion of patients with relapse over time (in days) from randomization. The graph compares the results between two treatments; a placebo and a medication called Duloxetine delayed-release. The graph displays the proportion of patients that experienced relapse, with higher numbers indicating a higher incidence of relapse. The x-axis shows the time period from randomization to relapse (in days), and the y-axis indicates the proportion of patients with relapse.*
Figure 2 - duloxetine 03
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 5 - duloxetine 06
Figure 6 - duloxetine 07
Figure 8 - duloxetine 08
This is a chart showing the percentage of patients who improved with a placebo and Duloxetine (60/120 mg taken once daily) for pain relief. The chart shows that 80% of patients improved with Duloxetine while 70% improved with a placebo. The percentages are shown on the y-axis while the percentage improvement in pain from baseline is shown on the x-axis.*
Figure 9 - duloxetine 09
This is a graph that shows the percentage of patients who experienced improvement in pain from baseline when taking either a placebo or a daily dose of 60mg of DUL. The x-axis shows the percentage improvement while the y-axis shows the number of patients. The graph indicates that there is a higher percentage of patients who experienced improvement in pain when taking the DUL medication compared to the placebo. However, there is not enough information provided to determine the exact percentage of patients who experienced improvement in pain.*
Figure 10 - duloxetine 10
This is a chart showing the percentage of patients who experienced improvement in pain from baseline while taking a drug named DULB0/120 mg once daily, compared to a placebo. The X-axis represents the percent improvement in pain from baseline, while the Y-axis represents different values ranging from 0 to 100.*
Label - lbl713350392
This is a medication package for a 30mg capsule of an unknown drug. It is compared to Cymbalta 30mg capsules. The package was put together by Bryant Ranck Prepack, and contains 30 capsules with an expiration date of MM/YY. The NDC number is 7133503921. It warns that the medication may cause drowsiness and should be stored at temperatures between 20°C-25°C (68°F-77°F). However, the name of the medication is not available in the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.